We are excited to share a major new publication co-authored by multiple GLUCOTYPES partners:
📄 Precision nutrition for cardiometabolic diseases, published in Nature Medicine.
🔗 Read the full article
This comprehensive review explores how advances in deep phenotyping, digital tools, and AI are transforming our understanding of dietary responses and individual nutrition needs. It critically examines the current evidence and outlines key challenges and opportunities to make precision nutrition a practical tool in cardiometabolic disease prevention and care.
👏 Congratulations to all authors involved — including several from the GLUCOTYPES consortium — for contributing to this landmark paper.
Abstract:
Precision nutrition is a vibrant and rapidly evolving field of scientific research and innovation with the potential to deliver health, societal, and economic benefits by improving healthcare delivery and policies. Advances in deep phenotyping technologies, digital tools, and artificial intelligence have made possible early proof-of-concept research that expands the understanding of within- and between-person variability in responses to diet. These studies illustrate the promise of precision nutrition to complement the traditional ‘one size fits all’ dietary guidelines, which, while considering broad life-stage and disease-specific nutritional requirements, often lack the granularity to account fully for individual variations in nutritional needs and dietary responses. Despite these developments, however, considerable challenges remain before precision nutrition can be implemented on a broader scale. This Review examines the current state of precision nutrition research, with a focus on its application to reducing the incidence and burden of cardiometabolic diseases. We critically examine the evidence base, explore the potential benefits, and discuss the challenges and opportunities ahead.
